Article History
Received: 19 June 2019
Accepted: 20 September 2019
First Online: 18 October 2019
Ethics approval and consent to participate
: Not applicable
: Not applicable
: BPK: None to declare. LF: Research funding from Abbvie, Bavarian Nordic, BMS, Dendreon, Janssen, Merck, Roche/Genentech. RKK: Research funding to institution for conduct of clinical trials from: Agios, Astra Zeneca, Bayer, BMS, Eli Lilly, Exelixis, Medimmune, Merck, Novartis, QED, Taiho. Steering Committee/Scientific Advisory Committee membership with funding support to institution from: Agios, Astra Zeneca, BMS, Merck. Consulting/IDMC funding to self from: Genentech/Roche, Target Pharma Solutions.